Journal: Prostate / Issue: Volume 73:Issue 12(2013) - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Journal Prostate Issue Volume 73:Issue 12(2013)

1. A novel hydroxysuberamide derivative potentiates MG132‐mediated anticancer activity against human hormone refractory prostate cancers—the role of histone deacetylase and endoplasmic reticulum stress. Issue 12 (28th June 2013)

Authors:: Chen, Yi‐Cheng; Huang, Wei‐Jan; Hsu, Jui‐Ling; Yu, Chia‐Chun; Wang, Wei‐Ting; Guh, Jih‐Hwa
Journal:: Prostate
Issue:: Volume 73:Issue 12(2013)
Page Start:: 1270
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. A novel hydroxysuberamide derivative potentiates MG132‐mediated anticancer activity against human hormone refractory prostate cancers—the role of histone deacetylase and endoplasmic reticulum stress. Issue 12 (28th June 2013)

Authors:: Chen, Yi‐Cheng; Huang, Wei‐Jan; Hsu, Jui‐Ling; Yu, Chia‐Chun; Wang, Wei‐Ting; Guh, Jih‐Hwa
Journal:: Prostate
Issue:: Volume 73:Issue 12(2013)
Page Start:: 1270
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer: A randomized controlled trial. Issue 12 (15th June 2013)

Authors:: Wright, Jonathan L.; Plymate, Stephen; D'Oria‐Cameron, Andrea; Bain, Carolyn; Haugk, Kathy; Xiao, Liren; Lin, Daniel W.; Stanford, Janet L.; McTiernan, Anne
Journal:: Prostate
Issue:: Volume 73:Issue 12(2013)
Page Start:: 1345
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer: A randomized controlled trial. Issue 12 (15th June 2013)

Authors:: Wright, Jonathan L.; Plymate, Stephen; D'Oria‐Cameron, Andrea; Bain, Carolyn; Haugk, Kathy; Xiao, Liren; Lin, Daniel W.; Stanford, Janet L.; McTiernan, Anne
Journal:: Prostate
Issue:: Volume 73:Issue 12(2013)
Page Start:: 1345
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Androgen receptor enhances entosis, a non‐apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells. Issue 12 (15th June 2013)

Authors:: Wen, Simeng; Shang, Zhiqun; Zhu, Shimiao; Chang, Chawnshang; Niu, Yuanjie
Journal:: Prostate
Issue:: Volume 73:Issue 12(2013)
Page Start:: 1306
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Androgen receptor enhances entosis, a non‐apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells. Issue 12 (15th June 2013)

Authors:: Wen, Simeng; Shang, Zhiqun; Zhu, Shimiao; Chang, Chawnshang; Niu, Yuanjie
Journal:: Prostate
Issue:: Volume 73:Issue 12(2013)
Page Start:: 1306
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Can delayed time to referral to a tertiary level urologist with an abnormal PSA level affect subsequent gleason grade in the opportunistically screened population?. Issue 12 (8th May 2013)

Authors:: O'Kelly, Fardod; Thomas, Arun; Murray, Denise; Galvin, David; Mulvin, David; Quinlan, David M.
Journal:: Prostate
Issue:: Volume 73:Issue 12(2013)
Page Start:: 1263
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Can delayed time to referral to a tertiary level urologist with an abnormal PSA level affect subsequent gleason grade in the opportunistically screened population?. Issue 12 (8th May 2013)

Authors:: O'Kelly, Fardod; Thomas, Arun; Murray, Denise; Galvin, David; Mulvin, David; Quinlan, David M.
Journal:: Prostate
Issue:: Volume 73:Issue 12(2013)
Page Start:: 1263
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration‐resistant prostate cancer. Issue 12 (13th June 2013)

Authors:: Guerrero, Javier; Alfaro, Iván E.; Gómez, Francisco; Protter, Andrew A.; Bernales, Sebastián
Journal:: Prostate
Issue:: Volume 73:Issue 12(2013)
Page Start:: 1291
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration‐resistant prostate cancer. Issue 12 (13th June 2013)

Authors:: Guerrero, Javier; Alfaro, Iván E.; Gómez, Francisco; Protter, Andrew A.; Bernales, Sebastián
Journal:: Prostate
Issue:: Volume 73:Issue 12(2013)
Page Start:: 1291
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗